Péter Diószeghy

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)

Claudia Trenkwalder, Bryan Kies, Monika Rudzińska et al. · Movement Disorders · 2010 · 440 citations · Full text

Medicine, Neurology, Pharmacology +17

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 200 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Everolimus for treatment-refractory seizures in TSC

David Neal Franz, John A. Lawson, Hiroko Ikeda et al. · Neurology Clinical Practice · 2018 · 107 citations · Full text

Medicine, Neurology, Pharmacotherapy +14